Chris Mizzo advocates for clients in high-stakes intellectual property and complex commercial litigation as part of Kirkland’s highly regarded trial team. In his national practice, Chris represents companies and individuals in state and federal courts across the country and before the U.S. International Trade Commission. He also conducts post-grant reviews before the U.S. Patent and Trademark Office.

Advising a diverse range of clients, from Fortune 100 companies to pioneering entrepreneurs, Chris tries cases stemming from disputes surrounding technologies and products in the pharmaceutical, semiconductor, communications and consumer household goods industries, among others.

With two decades of experience, Chris has first-chaired bet-the-company cases, including crucial litigation involving a life-saving drug. Having built reputations as tenacious, creative and strategically sound litigators, Chris and his team are sometimes called to “parachute in” and take over as trial counsel for clients in need of improving their chances of prevailing, often compelling an opposing side to settle the case rather than face off against the formidable Kirkland litigation team.

Chris relishes both the long, strenuous marathon of case preparation as well as the excitement of going to trial — pitting wits with an expert on cross examination or delivering the opening or closing statement, and always taking a reasonable and nuanced approach. He appreciates opportunities to stand before the court and represent his clients’ interests to the best of his ability. As a trusted advisor, Chris strives to ensure clients feel part of the team. He regularly updates clients on the status of their litigation, while being responsive and respectful of their time and the pressures they face.

An industrial engineering background gives Chris a solid grounding in science and an ability to quickly understand and assimilate information about the technology being litigated in IP cases. Additionally, his judicial clerkship experience informs the way Chris approaches trials because his grasp of the court’s perspective provides invaluable insight into framing cases more advantageously for clients.


Thought Leadership


F.C. Mizzo, L. Ben-Ami, J.M. Wacker, J. Bova and J. Lam, “Pharmaceutical IP and Competition Law in the United States: Overview”, Thomson Reuters Global Guide on Practical Law, June 1, 2018

S.M. Knowles and F.C. Mizzo, "The USPTO's Proposed Rule Changes & GlaxoSmithKline's Challenge to the Rules", The Sedona Conference, 2008

B.M. Wexler and F.C. Mizzo, "Unpublished Opinions Rising, But Do They Help?", New York Law Journal, February 11, 2002

Press Mentions

A number of news articles have described some of Chris’s notable cases and quoted him on a variety of IP subjects. The articles can be found here.


Presented on "The ABC’s of ITC: Patents and the International Trade Commission," GlaxoSmithKline’s Back to School of Law 2017, Chapel Hill, NC, Oct. 26, 2017           

Presented on "The PTO's New Rules Are Void: GlaxoSmithKline v. Dudas – Stories from the Front," 15th Annual Kirkland & Ellis Technology & Law Seminar, Chicago, IL, May 16, 2008

Panelist for "Open Forum: Ask the Judges About Patent Litigation," 13th Annual ALI-ABA Trial of a Patent Case, Chicago, IL, September 30, 2005

Memberships & Affiliations

American Bar Association


Admissions & Qualifications

  • 2000, New York
  • 2007, District of Columbia
  • Registered to practice before the United States Patent and Trademark Office


  • United States Court of Appeals for the Federal Circuit2000
  • United States District Court for the Southern District of New York2002
  • United States District Court for the Eastern District of New York2002
  • United States Court of Appeals for the Third Circuit2012


  • University of Virginia School of LawJ.D.1999
    Articles Editor, Virginia Journal of Law and Technology
  • Rutgers UniversityB.S., Industrial Engineeringsumma cum laude 1996